Staging biomarkers in preclinical autosomal dominant Alzheimer's disease by estimated years to symptom onset-Reference-Cited by-同舟云学术

Staging biomarkers in preclinical autosomal dominant Alzheimer's disease by estimated years to symptom onset

Published:2019-02-14 Issue:4 Volume:15 Page:506-514
ISSN:1552-5260
Container-title:Alzheimer's & Dementia
language:en
Short-container-title:Alzheimer's & Dementia

Author:

Wang Guoqiao¹,Coble Dean¹,McDade Eric M.²,Hassenstab Jason²,Fagan Anne M.²,Benzinger Tammie L.S.³,Bateman Randall J.²,Morris John C.²,Xiong Chengjie¹,

Affiliation:

1. Division of BiostatisticsWashington University School of MedicineSaint LouisMOUSA

2. Department of NeurologyWashington University School of MedicineSaint LouisMOUSA

3. Department of RadiologyWashington University School of MedicineSaint LouisMOUSA

Funder

National Institute on Aging

NIA

Publisher

Wiley

Subject

Psychiatry and Mental health,Cellular and Molecular Neuroscience,Geriatrics and Gerontology,Neurology (clinical),Developmental Neuroscience,Health Policy,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1016/j.jalz.2018.12.008

Reference32 articles.

1. Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease

2. Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

3. A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers

4. Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria

5. Longitudinal relationships among biomarkers for Alzheimer disease in the Adult Children Study

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Trials for Wolfram Syndrome Neurodegeneration: Novel Design, Endpoints, and Analysis Models;2024-09-11

2. 15 Years of Longitudinal Genetic, Clinical, Cognitive, Imaging, and Biochemical Measures in DIAN;2024-08-09

3. The CentiMarker Project: Standardizing Quantitative Alzheimer’s disease Fluid Biomarkers for Biologic Interpretation;2024-07-27

4. The effect of years of schooling and age on CERAD‐MX performance in Mexican preclinical carriers of the APP_V717I mutation: Randomized data simulation;Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring;2024-07

5. Novel non‐linear models for clinical trial analysis with longitudinal data: A tutorial using SAS for both frequentist and Bayesian methods;Statistics in Medicine;2024-05-10